1-9 of 9
Howard Weiner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results of a Phase II Study Investigating Dasatinib and Inotuzumab Ozogamicin-Based Induction for Newly-Diagnosed Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Anand Ashwin Patel, Adam S. Duvall, Caner Saygin, Howard Weiner, Emily Dworkin, Afsheen Noorani, Jamie Matthews, Rafael Madero Marroquin, Michael W Drazer, Mariam T. Nawas, Gregory W Roloff, Satyajit Kosuri, Michael J. Thirman, Richard A. Larson, Olatoyosi Odenike, Theodore Karrison, Wendy Stock
Journal: Blood
Blood (2024) 144 (Supplement 1): 1432.
https://doi.org/10.1182/blood-2024-193442
Published: 2024
Journal Articles

Final Analysis of a Phase I Study of Escalating Doses of the BCL-2 Inhibitor Venetoclax in Combination with Daunorubcin/Cytarabine Induction and High Dose Cytarabine Consolidation in Previously Untreated Adults with Acute Myeloid Leukemia

Richard M Stone, Daniel J. DeAngelo, Anthony G. Letai, Ilene A. Galinsky, Howard Weiner, Austen Halpin, Lexi Noyes, Hunter Smith, Carter Lombardi, Rebecca Leonard, Geoffrey Fell, Yael Flammand, Jeremy Ryan, Marina Konopleva, Martha Wadleigh, Maximilian Stahl, Evan Chen, Virginia O. Volpe, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Anand Ashwin Patel
Journal: Blood
Blood (2024) 144 (Supplement 1): 4261.
https://doi.org/10.1182/blood-2024-203683
Published: 2024
Journal Articles

Mini-Hyper-CVD Plus Venetoclax for Treatment of Older Adults with Newly Diagnosed Ph-Negative B-ALL or T-ALL

Marlise R. Luskin, Shai Shimony, Julia Keating, Wendy Stock, Hanno Hock, Jacqueline S. Garcia, Maximilian Stahl, Ilene Galinksy, Rebecca Leonard, Howard Weiner, Yael Flamand, Donna S. Neuberg, Richard M Stone, Anthony G. Letai, Eric S. Winer, Marina Y. Konopleva, Nitin Jain, Daniel J. DeAngelo
Journal: Blood
Blood (2023) 142 (Supplement 1): 2875.
https://doi.org/10.1182/blood-2023-174269
Published: 2023
Journal Articles

Therapy-Related Myeloid Neoplasms in 108 Patients Following Radiation Therapy Only

Anand Ashwin Patel, MD, Alexandra E Rojek, MD, Howard Weiner, Michael W. Drazer, MD, Lucy A. Godley, Michelle M. Le Beau, PhD, Richard A. Larson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-134433
Published: 2020
Journal Articles

Phase 1b Dose Escalation Study of BI 836858 and Azacitidine in Previously Untreated AML: Results from Beat AML S2

William Blum, MD, Amy S. Ruppert, MAS, PhD, Alice S. Mims, MD, Eytan M. Stein, MD, Vu H Duong, MD, Olatoyosi Odenike, MD, Prapti A. Patel, MD, Tibor Kovacsovics, MD, Nyla A. Heerema, PhD, Jo-Anne Vergilio, MD, Leonard Rosenberg, Sonja Marcus, MPH, Mona Stefanos, MBChB, Howard Weiner, Jake Brandt, Abigail Shoben, Brian J. Druker, MD, Amy Burd, PhD, Ross L. Levine, MD, John C. Byrd, MD, Uma Borate, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4053.
https://doi.org/10.1182/blood-2018-99-116199
Published: 2018
Journal Articles

Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)

Amy Wang, MD MPH, Howard Weiner, Richard A. Larson, MD, Olatoyosi Odenike, MD, Andrew S Artz, MD, Michael R. Bishop, MD, Lucy Godley, MD PhD, Michael Thirman, MD, Satyajit Kosuri, MD, Jane Churpek, MD, Emily K Curran, MD, Kristen Pettit, MD, Wendy Stock, MD, Hongtao Liu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4073.
https://doi.org/10.1182/blood-2018-99-120244
Published: 2018
Journal Articles

Therapy-Related Myeloid Neoplasms (t-MN) in 71 Patients Following Radiation Therapy (RT) Only,

Richard J Lin, M.D., Smita Joshi, M.D., Michelle M. Le Beau, PhD, Howard Weiner, Peggy Green, RN, Theodore Karrison, Ph.D., Richard A. Larson, MD
Journal: Blood
Blood (2011) 118 (21): 3522.
https://doi.org/10.1182/blood.V118.21.3522.3522
Published: 2011
Journal Articles

High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).

Sarah Larson, MD, Nicholas Campbell, MD, Dezheng Huo, PhD, Andrew Artz, MD, MS, Yanming Zhang, Devika Gajria, Margaret Green, Gamar Rahimova, Howard Weiner, Monica Torres, Olatoyosi Odenike, MD, Lucy A Godley, MD, PhD, Elizabeth Shima Rich, MD, PhD, Michael Thirman, MD, Richard A. Larson, MD, Wendy Stock, MD
Journal: Blood
Blood (2009) 114 (22): 1048.
https://doi.org/10.1182/blood.V114.22.1048.1048
Published: 2009
Journal Articles

Treatment of Therapy-Related Myeloid Neoplasms with High-Dose Cytarabine/Mitoxantrone Followed by Hematopoietic Cell Transplantation (HCT).

Lucy A Godley, Uchenna O. Njiaju, Margaret Green, Howard Weiner, Shang Lin, PhD, Olatoyosi Odenike, MD, Elizabeth Shima Rich, MD, PhD, Andrew Artz, MD, MS, Koen van Besien, MD, Christopher Daugherty, MD, Yanming Zhang, Michelle M. Le Beau, PhD, Wendy Stock, MD, Richard A. Larson, MD
Journal: Blood
Blood (2009) 114 (22): 1030.
https://doi.org/10.1182/blood.V114.22.1030.1030
Published: 2009